176 related articles for article (PubMed ID: 17086554)
1. WIP null mice display a progressive immunological disorder that resembles Wiskott-Aldrich syndrome.
Curcio C; Pannellini T; Lanzardo S; Forni G; Musiani P; Antón IM
J Pathol; 2007 Jan; 211(1):67-75. PubMed ID: 17086554
[TBL] [Abstract][Full Text] [Related]
2. Mutations that cause the Wiskott-Aldrich syndrome impair the interaction of Wiskott-Aldrich syndrome protein (WASP) with WASP interacting protein.
Stewart DM; Tian L; Nelson DL
J Immunol; 1999 Apr; 162(8):5019-24. PubMed ID: 10202051
[TBL] [Abstract][Full Text] [Related]
3. WIP and WASP play complementary roles in T cell homing and chemotaxis to SDF-1alpha.
Gallego MD; de la Fuente MA; Anton IM; Snapper S; Fuhlbrigge R; Geha RS
Int Immunol; 2006 Feb; 18(2):221-32. PubMed ID: 16141245
[TBL] [Abstract][Full Text] [Related]
4. A lentiviral vector encoding the human Wiskott-Aldrich syndrome protein corrects immune and cytoskeletal defects in WASP knockout mice.
Charrier S; Stockholm D; Seye K; Opolon P; Taveau M; Gross DA; Bucher-Laurent S; Delenda C; Vainchenker W; Danos O; Galy A
Gene Ther; 2005 Apr; 12(7):597-606. PubMed ID: 15616597
[TBL] [Abstract][Full Text] [Related]
5. A novel anti-WIP monoclonal antibody detects an isoform of WIP that lacks the WASP binding domain.
Koduru S; Massaad M; Wilbur C; Kumar L; Geha R; Ramesh N
Biochem Biophys Res Commun; 2007 Feb; 353(4):875-81. PubMed ID: 17207458
[TBL] [Abstract][Full Text] [Related]
6. WIP is a chaperone for Wiskott-Aldrich syndrome protein (WASP).
de la Fuente MA; Sasahara Y; Calamito M; Antón IM; Elkhal A; Gallego MD; Suresh K; Siminovitch K; Ochs HD; Anderson KC; Rosen FS; Geha RS; Ramesh N
Proc Natl Acad Sci U S A; 2007 Jan; 104(3):926-31. PubMed ID: 17213309
[TBL] [Abstract][Full Text] [Related]
7. A second-site mutation in the initiation codon of WAS (WASP) results in expansion of subsets of lymphocytes in an Wiskott-Aldrich syndrome patient.
Du W; Kumaki S; Uchiyama T; Yachie A; Yeng Looi C; Kawai S; Minegishi M; Ramesh N; Geha RS; Sasahara Y; Tsuchiya S
Hum Mutat; 2006 Apr; 27(4):370-5. PubMed ID: 16511828
[TBL] [Abstract][Full Text] [Related]
8. A peptide derived from the Wiskott-Aldrich syndrome (WAS) protein-interacting protein (WIP) restores WAS protein level and actin cytoskeleton reorganization in lymphocytes from patients with WAS mutations that disrupt WIP binding.
Massaad MJ; Ramesh N; Le Bras S; Giliani S; Notarangelo LD; Al-Herz W; Notarangelo LD; Geha RS
J Allergy Clin Immunol; 2011 Apr; 127(4):998-1005.e1-2. PubMed ID: 21376381
[TBL] [Abstract][Full Text] [Related]
9. Wiskott-Aldrich syndrome.
Notarangelo LD; Miao CH; Ochs HD
Curr Opin Hematol; 2008 Jan; 15(1):30-6. PubMed ID: 18043243
[TBL] [Abstract][Full Text] [Related]
10. WASP-WIP complex in the molecular pathogenesis of Wiskott-Aldrich syndrome.
Sasahara Y
Pediatr Int; 2016 Jan; 58(1):4-7. PubMed ID: 26331277
[TBL] [Abstract][Full Text] [Related]
11. FLI1 Induces Megakaryopoiesis Gene Expression Through WAS/WIP-Dependent and Independent Mechanisms; Implications for Wiskott-Aldrich Syndrome.
Wang C; Sample KM; Gajendran B; Kapranov P; Liu W; Hu A; Zacksenhaus E; Li Y; Hao X; Ben-David Y
Front Immunol; 2021; 12():607836. PubMed ID: 33717090
[TBL] [Abstract][Full Text] [Related]
12. WASP suppresses the growth defect of Saccharomyces cerevisiae las17Delta strain in the presence of WIP.
Rajmohan R; Meng L; Yu S; Thanabalu T
Biochem Biophys Res Commun; 2006 Apr; 342(2):529-36. PubMed ID: 16488394
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Wiskott-Aldrich syndrome (WAS) mutants using Saccharomyces cerevisiae.
Rajmohan R; Raodah A; Wong MH; Thanabalu T
FEMS Yeast Res; 2009 Dec; 9(8):1226-35. PubMed ID: 19817875
[TBL] [Abstract][Full Text] [Related]
14. Novel membrane cell projection defects in Wiskott-Aldrich syndrome B cells.
Andreu N; Aran JM; Fillat C
Int J Mol Med; 2007 Oct; 20(4):445-50. PubMed ID: 17786274
[TBL] [Abstract][Full Text] [Related]
15. Effects of Wiskott-Aldrich Syndrome Protein Deficiency on IL-10-Producing Regulatory B Cells in Humans and Mice.
Du HQ; Zhang X; An YF; Ding Y; Zhao XD
Scand J Immunol; 2015 Jun; 81(6):483-93. PubMed ID: 25728049
[TBL] [Abstract][Full Text] [Related]
16. WIP, a protein associated with wiskott-aldrich syndrome protein, induces actin polymerization and redistribution in lymphoid cells.
Ramesh N; Antón IM; Hartwig JH; Geha RS
Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14671-6. PubMed ID: 9405671
[TBL] [Abstract][Full Text] [Related]
17. Two novel mutations identified in the Wiskott-Aldrich syndrome protein gene cause Wiskott-Aldrich syndrome and thrombocytopenia.
Andreu N; Matamoros N; Escudero A; Fillat C
Int J Mol Med; 2007 May; 19(5):777-82. PubMed ID: 17390083
[TBL] [Abstract][Full Text] [Related]
18. Requirement for a complex of Wiskott-Aldrich syndrome protein (WASP) with WASP interacting protein in podosome formation in macrophages.
Tsuboi S
J Immunol; 2007 Mar; 178(5):2987-95. PubMed ID: 17312144
[TBL] [Abstract][Full Text] [Related]
19. Development of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndrome.
Boztug K; Dewey RA; Klein C
Curr Opin Mol Ther; 2006 Oct; 8(5):390-5. PubMed ID: 17078381
[TBL] [Abstract][Full Text] [Related]
20. Two novel mutations of Wiskott-Aldrich syndrome: the molecular prediction of interaction between the mutated WASP L101P with WASP-interacting protein by molecular modeling.
Kim MK; Kim ES; Kim DS; Choi IH; Moon T; Yoon CN; Shin JS
Biochim Biophys Acta; 2004 Oct; 1690(2):134-40. PubMed ID: 15469902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
